IT and IV Lentiviral Gene Therapy for X-ALD
NCT03727555
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
X-linked Adrenoleukodystrophy
Interventions
GENETIC:
Intrathecal and intravenous LV gene therapy
Sponsor
Shenzhen Geno-Immune Medical Institute